ATLASense develops the REPHAEL platform, a patented remote-health supervision platform covering all remote triage, intensive care, and home hospitalization monitoring needs.

The platform is tailored to the daily operational processes of caregivers, dynamically personalized according to each patient’s condition, and designed to generate patient-specific alerts for remote clinical decision support.The REPHAEL platform’s actionable data is based on its proprietary PolyMonitor wearable device technology, which collects an array of signals simultaneously and produces reliable and accurate diagnostic reports.

Through artificial intelligence and machine learning, these multiple streams can help develop new predictive analytic algorithms and applications for better preventive care.The current REPHAEL platform enables measurements of ECG 1-lead, heart rate, heart rate variability, arrhythmia detection (e.g., tachycardia, bradycardia, atrial fibrillation, ventricular premature beats, and ventricular tachycardia), respiration rate, obstructive and central apnea, hypopnea, noninvasive core temperature, cuffless noninvasive continuous blood pressure trending, skin conductance, stress/startle response, triaxial body position, and activity.